Y-mAbs Therapeutics, Inc. – IPO: ‘S-1’ on 8/24/18 – ‘EX-23.1’

On:  Friday, 8/24/18, at 10:48am ET   ·   Accession #:  1047469-18-5786   ·   File #:  333-226999

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.67M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     23K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     52K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     39K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    152K 
 6: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    242K 
 7: EX-4.3(A)   Instrument Defining the Rights of Security Holders  HTML    147K 
 8: EX-4.3(B)   Instrument Defining the Rights of Security Holders  HTML    146K 
 9: EX-4.3(C)   Instrument Defining the Rights of Security Holders  HTML    138K 
10: EX-10.1     Material Contract                                   HTML    240K 
19: EX-10.10    Material Contract                                   HTML     63K 
20: EX-10.11    Material Contract                                   HTML     89K 
21: EX-10.12    Material Contract                                   HTML     89K 
22: EX-10.13    Material Contract                                   HTML     82K 
23: EX-10.14    Material Contract                                   HTML     64K 
24: EX-10.15    Material Contract                                   HTML    373K 
25: EX-10.16    Material Contract                                   HTML     41K 
26: EX-10.17    Material Contract                                   HTML     42K 
27: EX-10.18    Material Contract                                   HTML     24K 
28: EX-10.19    Material Contract                                   HTML    127K 
11: EX-10.2     Material Contract                                   HTML    207K 
12: EX-10.3     Material Contract                                   HTML     92K 
13: EX-10.4     Material Contract                                   HTML    105K 
14: EX-10.5     Material Contract                                   HTML    217K 
15: EX-10.6     Material Contract                                   HTML    124K 
16: EX-10.7     Material Contract                                   HTML     99K 
17: EX-10.8     Material Contract                                   HTML     82K 
18: EX-10.9     Material Contract                                   HTML    131K 
30: EX-21.1     Subsidiaries                                        HTML      9K 
31: EX-23.1     Consent of Experts or Counsel                       HTML     10K 
29: EX-16.1     Letter re: Change in Certifying Accountant          HTML     14K 

EX-23.1   —   Consent of Experts or Counsel

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

Dates Referenced Herein

This ‘S-1’ Filing		Date		Other Filings
Filed on:		8/24/18		None on these Dates
		6/7/18
		5/18/18
				List all Filings

16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Y-mAbs Therapeutics, Inc.         S-8         2/29/24    4:185K                                   Toppan Merrill Bridge/FA
 2/29/24  Y-mAbs Therapeutics, Inc.         10-K       12/31/23  101:10M                                    Toppan Merrill Bridge/FA
 5/08/23  Y-mAbs Therapeutics, Inc.         10-Q        3/31/23   85:7.4M                                   Toppan Merrill Bridge/FA
 3/30/23  Y-mAbs Therapeutics, Inc.         S-8         3/30/23    4:168K                                   Toppan Merrill Bridge/FA
 3/30/23  Y-mAbs Therapeutics, Inc.         S-3                    5:975K                                   Toppan Merrill Bridge/FA
 3/30/23  Y-mAbs Therapeutics, Inc.         10-K       12/31/22  106:10M                                    Toppan Merrill Bridge/FA
 9/26/22  Y-mAbs Therapeutics, Inc.         8-K:5       9/22/22   10:187K                                   Toppan Merrill/FA
 5/09/22  Y-mAbs Therapeutics, Inc.         10-Q        3/31/22   85:7.2M                                   Toppan Merrill Bridge/FA
 3/01/22  Y-mAbs Therapeutics, Inc.         10-K       12/31/21   93:10M                                    Toppan Merrill Bridge/FA
11/04/21  Y-mAbs Therapeutics, Inc.         10-Q        9/30/21   76:7.4M                                   Toppan Merrill Bridge/FA
 8/09/21  Y-mAbs Therapeutics, Inc.         10-Q        6/30/21   76:7.2M                                   Toppan Merrill Bridge/FA
 5/06/21  Y-mAbs Therapeutics, Inc.         10-Q        3/31/21   76:6.3M                                   Toppan Merrill Bridge/FA
 3/01/21  Y-mAbs Therapeutics, Inc.         10-K       12/31/20   84:9.6M                                   Toppan Merrill Bridge/FA
11/05/20  Y-mAbs Therapeutics, Inc.         10-Q        9/30/20   68:6.7M                                   Toppan Merrill Bridge/FA
 8/06/20  Y-mAbs Therapeutics, Inc.         10-Q        6/30/20   68:5.6M                                   Toppan Merrill Bridge/FA
 8/30/18  SEC                               UPLOAD¶    10/19/18    2:49K  Y-mAbs Therapeutics, Inc.